サマリー

インスリン注射器の世界市場 2022-2026 年
Technavioはインスリン注射器市場を監視しており、2022-2026年の間に4億867万ドルの成長が見込まれ、予測期間中にCAGR 4.69%で加速しています。当レポートでは、インスリン注射器市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、糖尿病の世界的な負担の増加、政府の有利な取り組み、糖尿病自己管理教育プログラムの利用可能性などによって牽引されています。
インスリン注射器市場の分析には、タイプ別セグメントと地域別の展望が含まれます。
Technavioのインスリン注射器市場は、以下のようにセグメント化されています。
タイプ別
- 2型糖尿病
- 1型糖尿病
地理的状況別
- 北アメリカ
- 欧州
- APAC
- 南米
- 中東・アフリカ
本調査では、今後数年間のインスリン注射器市場の成長を促進する主な理由の1つとして、糖尿病に対する意識向上プログラムの増加を挙げています。また、インスリン注射器の販売を促進するための戦略的パートナーシップの上昇や、スマートインスリン注射器への注目の高まりは、市場の大規模な需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。インスリン注射器市場に関する当レポートは、以下の分野を対象としています。
- インシュリン注射器市場のサイジング
- インスリン注射器市場の予測
- インシュリン注射器市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AdvaCare Pharma、ASP Healthcare Pty Ltd.、Avantor Inc.、B. Braun SE、Becton Dickinson and Co,Cardinal Health Inc、CODAN Medizinische Gerate GmbH and Co KG、Gerresheimer AG、Healthwarehouse.com Inc、Hi-Tech Medics Pvt Ltd、Hindustan Syringes and Medical Devices Ltd、LAC Healthcare Solutions、Nipro Corp、Novo Nordisk AS、Poly Medicure Ltd、SCHOTT AG、Smiths Group Plc、Terumo Corp,サーモ・フィッシャーサイエンティフィック株式会社、ウルティメット・インクが含まれています。また、インスリン注射器市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/insulin-syringes-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Disease Type
o 5.1 Market segments
o Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
o 5.2 Comparison by Disease Type
o Exhibit 26: Chart on Comparison by Disease Type
o Exhibit 27: Data Table on Comparison by Disease Type
o 5.3 Type 2 diabetes - Market size and forecast 2021-2026
o Exhibit 28: Chart on Type 2 diabetes - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Type 2 diabetes - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Type 2 diabetes - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Type 2 diabetes - Year-over-year growth 2021-2026 (%)
o 5.4 Type 1 diabetes - Market size and forecast 2021-2026
o Exhibit 32: Chart on Type 1 diabetes - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Type 1 diabetes - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Type 1 diabetes - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Type 1 diabetes - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Disease Type
o Exhibit 36: Market opportunity by Disease Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 APAC - Market size and forecast 2021-2026
o Exhibit 50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on APAC - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
o 7.6 South America - Market size and forecast 2021-2026
o Exhibit 54: Chart on South America - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on South America - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on South America - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on South America - Year-over-year growth 2021-2026 (%)
o 7.7 Middle East and Africa - Market size and forecast 2021-2026
o Exhibit 58: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
o 7.8 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.9 Canada - Market size and forecast 2021-2026
o Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.10 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 France - Market size and forecast 2021-2026
o Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)
o 7.13 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 B. Braun SE
o Exhibit 89: B. Braun SE - Overview
o Exhibit 90: B. Braun SE - Business segments
o Exhibit 91: B. Braun SE - Key news
o Exhibit 92: B. Braun SE - Key offerings
o Exhibit 93: B. Braun SE - Segment focus
o 10.4 Becton Dickinson and Co.
o Exhibit 94: Becton Dickinson and Co. - Overview
o Exhibit 95: Becton Dickinson and Co. - Business segments
o Exhibit 96: Becton Dickinson and Co. - Key news
o Exhibit 97: Becton Dickinson and Co. - Key offerings
o Exhibit 98: Becton Dickinson and Co. - Segment focus
o 10.5 Cardinal Health Inc
o Exhibit 99: Cardinal Health Inc - Overview
o Exhibit 100: Cardinal Health Inc - Business segments
o Exhibit 101: Cardinal Health Inc - Key news
o Exhibit 102: Cardinal Health Inc - Key offerings
o Exhibit 103: Cardinal Health Inc - Segment focus
o 10.6 CODAN Medizinische Gerate GmbH and Co KG
o Exhibit 104: CODAN Medizinische Gerate GmbH and Co KG - Overview
o Exhibit 105: CODAN Medizinische Gerate GmbH and Co KG - Product / Service
o Exhibit 106: CODAN Medizinische Gerate GmbH and Co KG - Key offerings
o 10.7 Gerresheimer AG
o Exhibit 107: Gerresheimer AG - Overview
o Exhibit 108: Gerresheimer AG - Business segments
o Exhibit 109: Gerresheimer AG - Key news
o Exhibit 110: Gerresheimer AG - Key offerings
o Exhibit 111: Gerresheimer AG - Segment focus
o 10.8 Hindustan Syringes and Medical Devices Ltd.
o Exhibit 112: Hindustan Syringes and Medical Devices Ltd. - Overview
o Exhibit 113: Hindustan Syringes and Medical Devices Ltd. - Product / Service
o Exhibit 114: Hindustan Syringes and Medical Devices Ltd. - Key offerings
o 10.9 Nipro Corp.
o Exhibit 115: Nipro Corp. - Overview
o Exhibit 116: Nipro Corp. - Business segments
o Exhibit 117: Nipro Corp. - Key offerings
o Exhibit 118: Nipro Corp. - Segment focus
o 10.10 SCHOTT AG
o Exhibit 119: SCHOTT AG - Overview
o Exhibit 120: SCHOTT AG - Business segments
o Exhibit 121: SCHOTT AG - Key news
o Exhibit 122: SCHOTT AG - Key offerings
o Exhibit 123: SCHOTT AG - Segment focus
o 10.11 Smiths Group Plc
o Exhibit 124: Smiths Group Plc - Overview
o Exhibit 125: Smiths Group Plc - Business segments
o Exhibit 126: Smiths Group Plc - Key news
o Exhibit 127: Smiths Group Plc - Key offerings
o Exhibit 128: Smiths Group Plc - Segment focus
o 10.12 Terumo Corp.
o Exhibit 129: Terumo Corp. - Overview
o Exhibit 130: Terumo Corp. - Business segments
o Exhibit 131: Terumo Corp. - Key news
o Exhibit 132: Terumo Corp. - Key offerings
o Exhibit 133: Terumo Corp. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 134: Inclusions checklist
o Exhibit 135: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 136: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 137: Research methodology
o Exhibit 138: Validation techniques employed for market sizing
o Exhibit 139: Information sources
o 11.5 List of abbreviations
o Exhibit 140: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Disease Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Disease Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Disease Type
Exhibits27: Data Table on Comparison by Disease Type
Exhibits28: Chart on Type 2 diabetes - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Type 2 diabetes - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Type 2 diabetes - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Type 2 diabetes - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Type 1 diabetes - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Type 1 diabetes - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Type 1 diabetes - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Type 1 diabetes - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Disease Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on APAC - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on APAC - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on South America - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on South America - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on South America - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on South America - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: B. Braun SE - Overview
Exhibits90: B. Braun SE - Business segments
Exhibits91: B. Braun SE - Key news
Exhibits92: B. Braun SE - Key offerings
Exhibits93: B. Braun SE - Segment focus
Exhibits94: Becton Dickinson and Co. - Overview
Exhibits95: Becton Dickinson and Co. - Business segments
Exhibits96: Becton Dickinson and Co. - Key news
Exhibits97: Becton Dickinson and Co. - Key offerings
Exhibits98: Becton Dickinson and Co. - Segment focus
Exhibits99: Cardinal Health Inc - Overview
Exhibits100: Cardinal Health Inc - Business segments
Exhibits101: Cardinal Health Inc - Key news
Exhibits102: Cardinal Health Inc - Key offerings
Exhibits103: Cardinal Health Inc - Segment focus
Exhibits104: CODAN Medizinische Gerate GmbH and Co KG - Overview
Exhibits105: CODAN Medizinische Gerate GmbH and Co KG - Product / Service
Exhibits106: CODAN Medizinische Gerate GmbH and Co KG - Key offerings
Exhibits107: Gerresheimer AG - Overview
Exhibits108: Gerresheimer AG - Business segments
Exhibits109: Gerresheimer AG - Key news
Exhibits110: Gerresheimer AG - Key offerings
Exhibits111: Gerresheimer AG - Segment focus
Exhibits112: Hindustan Syringes and Medical Devices Ltd. - Overview
Exhibits113: Hindustan Syringes and Medical Devices Ltd. - Product / Service
Exhibits114: Hindustan Syringes and Medical Devices Ltd. - Key offerings
Exhibits115: Nipro Corp. - Overview
Exhibits116: Nipro Corp. - Business segments
Exhibits117: Nipro Corp. - Key offerings
Exhibits118: Nipro Corp. - Segment focus
Exhibits119: SCHOTT AG - Overview
Exhibits120: SCHOTT AG - Business segments
Exhibits121: SCHOTT AG - Key news
Exhibits122: SCHOTT AG - Key offerings
Exhibits123: SCHOTT AG - Segment focus
Exhibits124: Smiths Group Plc - Overview
Exhibits125: Smiths Group Plc - Business segments
Exhibits126: Smiths Group Plc - Key news
Exhibits127: Smiths Group Plc - Key offerings
Exhibits128: Smiths Group Plc - Segment focus
Exhibits129: Terumo Corp. - Overview
Exhibits130: Terumo Corp. - Business segments
Exhibits131: Terumo Corp. - Key news
Exhibits132: Terumo Corp. - Key offerings
Exhibits133: Terumo Corp. - Segment focus
Exhibits134: Inclusions checklist
Exhibits135: Exclusions checklist
Exhibits136: Currency conversion rates for US$
Exhibits137: Research methodology
Exhibits138: Validation techniques employed for market sizing
Exhibits139: Information sources
Exhibits140: List of abbreviations